Review



e4bp4  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec e4bp4
    E4bp4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/Naive+CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/pm42471227-91-17-26
    Average 96 stars, based on 142 article reviews
    e4bp4 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Protocol for potent activation of T cells using BPI-stimulated murine bone marrow-derived cells
    Article Snippet: .. • To analyze (naïve) CD8 + T cells, use the murine “naïve CD8a + T-Cell Isolation Kit” from Miltenyi Biotech (130-096-543) in steps 10 and 11. ..

    Article Title: E4BP4 restrains effector-memory CD8 + T cell responses in systemic lupus erythematosus.
    Article Snippet: .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions. .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions.

    Article Title: Enzymatic attachment of antigens to probe immune modulation by skin commensals
    Article Snippet: After spinning the splenocytes at 550 g for 5 min at 4 °C, the red blood cells were lysed using 1 ml of Ack lysis buffer for 5 min at room temperature (Thermo Scientific, # A1049201). .. T cells were then isolated using naïve CD4 and CD8 T cell isolation kits, where appropriate following manufacturing guidelines (Milteny, 130-104-453 or 130-096-543). .. T cells were then counted and rested for at least 30 min in complete RPMI (cRPMI = RPMI (Thermo Fisher, 61870127) supplemented with Penicillin-Streptomycin (Thermo Fisher, 15140122), HEPES (Thermo Fisher, 15630080), non-essential amino acids (Thermo Fisher, 11140050), sodium pyruvate (Thermo Fisher, 11360070), β-mercaptoethanol (Life Technologies Corporation, 21985023) and 10% FBS (GeminiBio)).

    Purification:

    Article Title: Therapeutic Poxviruses Induce the Secretion of Immunostimulating and Anti‐Tumoral Extracellular Vesicles
    Article Snippet: .. Naïve CD8 + T cells were purified with a mouse Naïve CD8a + T cell Isolation Kit (MiltenyiBiotec #130‐096‐543). .. Purified naïve CD8 + T cells purity was assessed by flow cytometry on a Attune NxT (Invitrogen) flow cytometer using FITC anti‐CD4 (1:100, clone RM4‐5, BioLegend #100510), BV605 anti‐CD8 (1:200, clone 53–6.7, BioLegend #100743), PE anti‐CD44 (1:200, clone IM7, BioLegend #103024), PE‐Cy7 anti‐TCR Va2 (1:100, clone B20.1, BioLegend #103024), and APC anti‐TCR Vb5.1, 5.2 (1:100, clone MR9‐4, BioLegend #139506) staining and ranged from 95.7 to 99.8 (median 99.3%).

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.

    Cell Isolation:

    Article Title: Therapeutic Poxviruses Induce the Secretion of Immunostimulating and Anti‐Tumoral Extracellular Vesicles
    Article Snippet: .. Naïve CD8 + T cells were purified with a mouse Naïve CD8a + T cell Isolation Kit (MiltenyiBiotec #130‐096‐543). .. Purified naïve CD8 + T cells purity was assessed by flow cytometry on a Attune NxT (Invitrogen) flow cytometer using FITC anti‐CD4 (1:100, clone RM4‐5, BioLegend #100510), BV605 anti‐CD8 (1:200, clone 53–6.7, BioLegend #100743), PE anti‐CD44 (1:200, clone IM7, BioLegend #103024), PE‐Cy7 anti‐TCR Va2 (1:100, clone B20.1, BioLegend #103024), and APC anti‐TCR Vb5.1, 5.2 (1:100, clone MR9‐4, BioLegend #139506) staining and ranged from 95.7 to 99.8 (median 99.3%).

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Article Title: E4BP4 restrains effector-memory CD8 + T cell responses in systemic lupus erythematosus.
    Article Snippet: .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions. .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions.

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.

    Article Title: Enzymatic attachment of antigens to probe immune modulation by skin commensals
    Article Snippet: After spinning the splenocytes at 550 g for 5 min at 4 °C, the red blood cells were lysed using 1 ml of Ack lysis buffer for 5 min at room temperature (Thermo Scientific, # A1049201). .. T cells were then isolated using naïve CD4 and CD8 T cell isolation kits, where appropriate following manufacturing guidelines (Milteny, 130-104-453 or 130-096-543). .. T cells were then counted and rested for at least 30 min in complete RPMI (cRPMI = RPMI (Thermo Fisher, 61870127) supplemented with Penicillin-Streptomycin (Thermo Fisher, 15140122), HEPES (Thermo Fisher, 15630080), non-essential amino acids (Thermo Fisher, 11140050), sodium pyruvate (Thermo Fisher, 11360070), β-mercaptoethanol (Life Technologies Corporation, 21985023) and 10% FBS (GeminiBio)).

    Article Title: Host Metadherin Coordinates Hepatic Lipid metabolism and CD8 + T-Cell Immunity to Promote Tumor Progression
    Article Snippet: Standard Macrophage Depletion Kit (Clodrosome + Encapsome) , Encapsula NanoSciences , Cat#CLD-8901. .. Naive CD8a+ T Cell Isolation Kit, mouse , Miltenyi Biotec , Cat#130-096-543. .. CD8a+ T Cell Isolation Kit, mouse , Miltenyi Biotec , Cat#130-104-075.

    Single Cell:

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Staining:

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Selection:

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.



    Similar Products

    95
    Miltenyi Biotec anti cd3 antibodies
    Anti Cd3 Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/CD8a+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__11__03__763975-36-3-5
    Average 95 stars, based on 1 article reviews
    anti cd3 antibodies - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec mouse cd8 t cell isolation kit
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Mouse Cd8 T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/bio_rxiv__64898__2026__11__02__763646-492-11-17
    Average 97 stars, based on 1 article reviews
    mouse cd8 t cell isolation kit - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd8 t cell isolation kits
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Cd8 T Cell Isolation Kits, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/Naive+CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/bio_rxiv__64898__2026__10__31__763323-95-9-19
    Average 96 stars, based on 1 article reviews
    cd8 t cell isolation kits - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec t cells
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    T Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/CD8a+(Ly-2)+MicroBeads%2C+mouse/bio_rxiv__64898__2026__10__30__763208-340-5-10
    Average 96 stars, based on 1 article reviews
    t cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec magnet activated cell sorting macs columns
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Magnet Activated Cell Sorting Macs Columns, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/pm42887583-76-18-30
    Average 97 stars, based on 1 article reviews
    magnet activated cell sorting macs columns - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    93
    Cytek Biosciences anti cd8a
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Anti Cd8a, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/PE-Cyanine7+Anti-Human+CD8a/pm42880242-230-60-63
    Average 93 stars, based on 1 article reviews
    anti cd8a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd8a
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Anti Cd8a, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/InVivoMAb+anti-mouse+CD8%CE%B1/pm42875546-459-7-8
    Average 97 stars, based on 1 article reviews
    anti cd8a - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    Bio X Cell cd8a
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Cd8a, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/InVivoMAb+anti-mouse+CD8%CE%B1/pmc13684881-957-0-4
    Average 95 stars, based on 1 article reviews
    cd8a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Proteintech anti mouse cd8α fitc
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Anti Mouse Cd8α Fitc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a/FITC+Anti-mouse+CD8a/pm42869007-863-25-27
    Average 93 stars, based on 1 article reviews
    anti mouse cd8α fitc - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, CD8+ and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, CD8+ and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Gene Set Enrichment Analysis, Concentration Assay, Control, Ex Vivo, Analysis, Expressing, Immune Cell, Neutralization

    (A) Concentration of IFNα1 and IFNβ in ear skin lysates in T2 memory (n=3 (D0), 4 (D36, D37) mice). (B) Flow cytometry assessment of residency-associated markers CD69 and CD103 on CD8+ T cells in recovered D36 skin (n=5 mice). (C) Ear thickness curves across primary to tertiary MC903 challenge (n=5 mice). (D) Abundance of CD8+ Trm and Ccl1 + CD8+ Trm relative to full tissue ecosystem over T2 memory timepoints. (E) gMFI of IFNγ in D37 skin samples assessed by flow cytometry across 2 different panels to separately capture NK1.1+ and CD4+ T cells (n=6 mice/panel). (F) Representative H&E images from later primary T2 timepoints capturing peak (D10) and late resolution (D21). (G) Extended primary ear thickness curve during primary CD8+ T cell depletion in T2 inflammation (n=5 mice/group) and (H) flow cytometry results on D39 (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (I) Flow cytometric analysis of CD8+ T cells in blood and skin on D36 after circulating CD8+ T cell depletion (n=3 mice). (J) Extended ear thickness curve for primary and memory T2 inflammation under primary IFNγ neutralization (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Concentration of IFNα1 and IFNβ in ear skin lysates in T2 memory (n=3 (D0), 4 (D36, D37) mice). (B) Flow cytometry assessment of residency-associated markers CD69 and CD103 on CD8+ T cells in recovered D36 skin (n=5 mice). (C) Ear thickness curves across primary to tertiary MC903 challenge (n=5 mice). (D) Abundance of CD8+ Trm and Ccl1 + CD8+ Trm relative to full tissue ecosystem over T2 memory timepoints. (E) gMFI of IFNγ in D37 skin samples assessed by flow cytometry across 2 different panels to separately capture NK1.1+ and CD4+ T cells (n=6 mice/panel). (F) Representative H&E images from later primary T2 timepoints capturing peak (D10) and late resolution (D21). (G) Extended primary ear thickness curve during primary CD8+ T cell depletion in T2 inflammation (n=5 mice/group) and (H) flow cytometry results on D39 (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (I) Flow cytometric analysis of CD8+ T cells in blood and skin on D36 after circulating CD8+ T cell depletion (n=3 mice). (J) Extended ear thickness curve for primary and memory T2 inflammation under primary IFNγ neutralization (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Concentration Assay, Flow Cytometry, Tissue, Analysis, Neutralization

    (A) Schematic of 5′ scRNA-seq of sorted CD8+ T cells from D36 and D37 skin to capture Trm, Teff and Tmem cells. (B) UMAP embedding of 7,708 CD8+ T cells across 20 mice (n = 10/timepoint) coloured by cell state. (C) Violin plot depicting expression levels of CD8+ T cell lineage markers along with T2 and T1 effector molecules across all CD8+ T cell states. (D) Intracellular staining of IFNγ and IL-13 across CD103+ CD8+ Trm cells on D36, D37, D72 and D73 skin (n=7 (D36), 8 (D37), 3 (D72), 6 (D73) mice) with (E) representative flow plots for D37 and D73. (F) Flow cytometric quantification of TNF-α production across immune cell types on D37 (n=4 mice). (G) Quantification of abundance and gMFI of GZMB expression across lymphoid populations in D37 (n=9 (% GZMB ), 4 (gMFI) mice). (H) UMAP embedding of 67,173 T cells across 95 patients and 5 studies integrated using Harmony where cell subtypes are annotated and cell clusters are coloured. Study information and clustering details are provided in . (I) Mapping of top 100 genes defining murine allergic Ccl1 + CD8+ Trm state as a gene module across human T cell clusters using patient-level pseudobulk GSVA. (J) Dot plot of lineage-defining, T2 and T1 effector molecule expression across Trm cell subsets. (K) Cell cluster abundances were correlated against Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) scores. Significant associations are highlighted. (L) Quantification of CCL1 + CD8+ Trm cells in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=34 (H), 20 (NL), 41 (L)patients).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Schematic of 5′ scRNA-seq of sorted CD8+ T cells from D36 and D37 skin to capture Trm, Teff and Tmem cells. (B) UMAP embedding of 7,708 CD8+ T cells across 20 mice (n = 10/timepoint) coloured by cell state. (C) Violin plot depicting expression levels of CD8+ T cell lineage markers along with T2 and T1 effector molecules across all CD8+ T cell states. (D) Intracellular staining of IFNγ and IL-13 across CD103+ CD8+ Trm cells on D36, D37, D72 and D73 skin (n=7 (D36), 8 (D37), 3 (D72), 6 (D73) mice) with (E) representative flow plots for D37 and D73. (F) Flow cytometric quantification of TNF-α production across immune cell types on D37 (n=4 mice). (G) Quantification of abundance and gMFI of GZMB expression across lymphoid populations in D37 (n=9 (% GZMB ), 4 (gMFI) mice). (H) UMAP embedding of 67,173 T cells across 95 patients and 5 studies integrated using Harmony where cell subtypes are annotated and cell clusters are coloured. Study information and clustering details are provided in . (I) Mapping of top 100 genes defining murine allergic Ccl1 + CD8+ Trm state as a gene module across human T cell clusters using patient-level pseudobulk GSVA. (J) Dot plot of lineage-defining, T2 and T1 effector molecule expression across Trm cell subsets. (K) Cell cluster abundances were correlated against Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) scores. Significant associations are highlighted. (L) Quantification of CCL1 + CD8+ Trm cells in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=34 (H), 20 (NL), 41 (L)patients).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Expressing, Staining, Immune Cell

    (A) UMAP embedding of 7,708 CD8+ T cells recovered, split by timepoint (n=10 mice/timepoint). (B) Violin plot showing representative markers of CD8+ Trm1, Trm17, Teff and Tmem cell states. (C) Stacked bar plot showing cell state abundances on a per-mouse basis across 10 mice per timepoint. (D) CITE-seq assessment of cell surface CD103, CD69, CD62L and CD44 levels across CD8+ Trm1, Trm17, Tmem and Teff populations. (E) Flow cytometric assessment of TNF-α gMFI on D37 across lymphoid and myeloid lineages in skin (n=4 mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) UMAP embedding of 7,708 CD8+ T cells recovered, split by timepoint (n=10 mice/timepoint). (B) Violin plot showing representative markers of CD8+ Trm1, Trm17, Teff and Tmem cell states. (C) Stacked bar plot showing cell state abundances on a per-mouse basis across 10 mice per timepoint. (D) CITE-seq assessment of cell surface CD103, CD69, CD62L and CD44 levels across CD8+ Trm1, Trm17, Tmem and Teff populations. (E) Flow cytometric assessment of TNF-α gMFI on D37 across lymphoid and myeloid lineages in skin (n=4 mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques:

    (A) 5 public scRNA-seq datasets of AD skin featuring full thickness and suction blister biopsies (GSE147424, GSE230575, GSE204765, GSE153760, GSE158432) were integrated using Harmony and re-annotated to produce a final dataset of 568,080 cells across 95 patients. Additional details in Methods. (B) UMAP embedding of 568,080 cells showing annotated cell types from one round of clustering defined using markers specified in Methods. (C) T cells ( CD3E + CD3D +) were subclustered and cluster-defining marker expression is displayed. Related UMAP is shown in  . (D) Stacked bar chart showing cell patient biopsy. (E) Quantification of additional cell clusters in addition to  for their abundances in each biopsy across healthy (H), non-lesional (w)oannganesionliavel l (NL) and lesional (L) ski (H),Shift(NL), 41 (L) patients).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) 5 public scRNA-seq datasets of AD skin featuring full thickness and suction blister biopsies (GSE147424, GSE230575, GSE204765, GSE153760, GSE158432) were integrated using Harmony and re-annotated to produce a final dataset of 568,080 cells across 95 patients. Additional details in Methods. (B) UMAP embedding of 568,080 cells showing annotated cell types from one round of clustering defined using markers specified in Methods. (C) T cells ( CD3E + CD3D +) were subclustered and cluster-defining marker expression is displayed. Related UMAP is shown in . (D) Stacked bar chart showing cell patient biopsy. (E) Quantification of additional cell clusters in addition to for their abundances in each biopsy across healthy (H), non-lesional (w)oannganesionliavel l (NL) and lesional (L) ski (H),Shift(NL), 41 (L) patients).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Marker, Expressing

    (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Expressing, Flow Cytometry, Isolation, Staining, Injection

    (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Neutralization, Injection, Stable Transfection, RNA Sequencing, Transfection, Expressing, Variant Assay

    (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Analysis, Expressing, Single Cell, Immune Cell, Blocking Assay, Control, Migration, Flow Cytometry, Derivative Assay, RNA Sequencing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Significance Assay, Gene Expression

    Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Derivative Assay, Amplification